Merit Medical Systems Shares Outstanding 2006-2020 | MMSI

Merit Medical Systems shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Merit Medical Systems Annual Shares Outstanding
(Millions of Shares)
2019 56
2018 54
2017 50
2016 45
2015 45
2014 43
2013 43
2012 43
2011 40
2010 36
2009 36
2008 36
2007 35
2006 35
2005 35
Merit Medical Systems Quarterly Shares Outstanding
(Millions of Shares)
2020-06-30 55
2020-03-31 55
2019-12-31 56
2019-09-30 55
2019-06-30 57
2019-03-31 56
2018-12-31 54
2018-09-30 55
2018-06-30 52
2018-03-31 52
2017-12-31 50
2017-09-30 52
2017-06-30 51
2017-03-31 46
2016-12-31 45
2016-09-30 45
2016-06-30 45
2016-03-31 45
2015-12-31 45
2015-09-30 45
2015-06-30 45
2015-03-31 44
2014-12-31 43
2014-09-30 43
2014-06-30 43
2014-03-31 43
2013-12-31 43
2013-09-30 43
2013-06-30 43
2013-03-31 43
2012-12-31 43
2012-09-30 43
2012-06-30 42
2012-03-31 42
2011-12-31 40
2011-09-30 43
2011-06-30 38
2011-03-31 36
2010-12-31 36
2010-09-30 35
2010-06-30 36
2010-03-31 36
2009-12-31 36
2009-09-30 36
2009-06-30 36
2009-03-31 36
2008-12-31 36
2008-09-30 36
2008-06-30 35
2008-03-31 35
2007-12-31 35
2007-09-30 35
2007-06-30 36
2007-03-31 36
2006-12-31 35
2006-09-30 35
2006-06-30 35
2006-03-31 35
2005-12-31 35
2005-09-30 35
2005-06-30 35
2005-03-31 34
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.341B $0.995B
Merit Medical Systems, Inc. set out to build the world's most customer-focused healthcare company by understanding customers' needs, and innovating and delivering a diverse range of products that improve the lives of people, families, and communities throughout the world. Merit's primary products consist of inflation devices used in angioplasty and stent placement; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; diagnostic and hydrophilic products used to manage and monitor the administration of contrast media and other fluid solutions; thrombolytic catheters and fluid dispensing systems; and embolotherapeutic products for the treatment of uterine fibroids, hypervascularised tumours, and arteriovenous malformations; and procedural trays, packs, and kits.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.221B 21.65
Align Technology (ALGN) United States $25.288B 14.93
McKesson (MCK) United States $24.674B 10.53
West Pharmaceutical Services (WST) United States $20.508B 71.76
AmerisourceBergen (ABC) United States $19.767B 12.71
Cooper (COO) United States $18.479B 35.42
Laboratory Of America Holdings (LH) United States $17.863B 17.14
Straumann Holding AG (SAUHF) Switzerland $16.384B 0.00
Cardinal Health (CAH) United States $13.944B 8.75
DENTSPLY SIRONA (XRAY) United States $10.123B 29.89
Henry Schein (HSIC) United States $8.705B 21.70
SmileDirectClub (SDC) United States $4.561B 0.00
STAAR Surgical (STAA) United States $2.563B 180.48
Patterson (PDCO) United States $2.287B 14.65
CONMED (CNMD) United States $2.218B 39.61
Atrion (ATRI) United States $1.201B 34.66
Antares Pharma (ATRS) United States $0.475B 71.50
Invacare (IVC) United States $0.253B 0.00
Retractable Technologies (RVP) United States $0.246B 39.26
Lifevantage (LFVN) United States $0.192B 15.74
Pro-Dex (PDEX) United States $0.110B 26.39
Milestone Scientific (MLSS) United States $0.090B 0.00
Biolase (BIOL) United States $0.028B 0.00